...
首页> 外文期刊>BMC Hematology >Prevalence of thrombocytopenia before and after initiation of HAART among HIV infected patients at black lion specialized hospital, Addis Ababa, Ethiopia: a cross sectional study
【24h】

Prevalence of thrombocytopenia before and after initiation of HAART among HIV infected patients at black lion specialized hospital, Addis Ababa, Ethiopia: a cross sectional study

机译:在埃塞俄比亚亚的斯亚贝巴的黑狮专科医院,HIV感染患者中发生HAART前后血小板减少症的患病率:一项横断面研究

获取原文
           

摘要

Background Hematological abnormalities are common in HIV positive patients. Of these, thrombocytopenia is a known complication which has been associated with a variety of bleeding disorders. However, its magnitude and related factors have not been well-characterized in the era of highly active antiretroviral therapy (HAART) in Ethiopia. Therefore, this study aimed to assess the prevalence of thrombocytopenia before and after initiation of HAART among HIV positive patients attending Black Lion Specialized Hospital, Addis Ababa, Ethiopia. Methods A cross sectional study was conducted from February to April 2017 in Black Lion Specialized Hospital, Addis Ababa, Ethiopia. A total of 176 patients on HAART were selected using simple random sampling techniques. Socio-demographic and clinical characteristics of the study patients were collected using structured questionnaire. Measurements of platelet counts and CD4?+?T cell counts were made using Sysmex XT 2000i hematology analyzer and BD FACS Count CD4 analyzer, respectively. Statistical analysis of the data (Paired T- test and binary logistic regression) was done using SPSS version 20. P -value ?18?years old) were enrolled in this study and had a mean age of 40.08?±?9.38?years. There was significant increase in the mean values of platelet counts (218.44?±?106.6?×?103/μl vs 273.65?±?83.8?×?103/μl, p
机译:背景血液学异常在HIV阳性患者中很常见。其中,血小板减少症是一种已知的并发症,与多种出血性疾病有关。但是,在埃塞俄比亚高效抗逆转录病毒疗法(HAART)时代,其强度和相关因素尚未得到很好的表征。因此,本研究旨在评估在埃塞俄比亚亚的斯亚贝巴的黑狮专科医院的HIV阳性患者中,HAART启动前后血小板减少症的患病率。方法2017年2月至2017年4月在埃塞俄比亚亚的斯亚贝巴的黑狮专科医院进行了横断面研究。使用简单的随机抽样技术选择了总共176例接受HAART治疗的患者。使用结构化问卷收集研究患者的社会人口统计学和临床​​特征。分别使用Sysmex XT 2000i血液分析仪和BD FACS Count CD4分析仪进行血小板计数和CD4 ++ T细胞计数的测量。使用SPSS 20版对数据进行统计学分析(配对T检验和二元logistic回归),该研究纳入了P值“ 18岁”,平均年龄为40.08±9.38岁。血小板计数平均值显着增加(218.44?±?106.6?×?10 3 /μl与273.65?±?83.8?×?10 3 /与基线相比,HAART起始六个月后为μl,p <?0.001)。 HAART启动之前和之后的血小板减少症患病率分别为25%和5.7%。与CD4计数≥350细胞/μl的HIV患者相比,CD4计数<200个细胞/μl的HIV患者更容易出现血小板减少。但是,它与血小板减少症的患病率没有统计学联系。结论这项研究表明,HAART启动后血小板减少症的患病率显着降低。根据我们的结果,许多研究参与者在开始进行HAART后仍存在血小板减少症。因此,应该对HIV感染患者进行血小板减少症的连续筛查,以降低发病率和死亡率。

著录项

相似文献

  • 外文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号